Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Canadian Pacific Kansas City | CP | May 31, 2024 | 79.36 | +2.31 |
Canadian Solar | CSIQ | May 31, 2024 | 19.64 | -0.05 |
Candel Therapeutics | CADL | May 31, 2024 | 8.90 | +3.25 |
Cango ADR | CANG | May 31, 2024 | 1.49 | -1.97 |
Canna-Global Acquisition A | CNGL | May 31, 2024 | 11.36 | +0.44 |
Canna-Global Acquisition Unit | CNGLU | May 31, 2024 | 10.85 | 0.00 |
Cannae | CNNE | May 31, 2024 | 18.18 | -0.33 |
Canoo A | GOEV | May 31, 2024 | 2.25 | +7.66 |
Canopy Growth | CGC | May 31, 2024 | 8.53 | -0.70 |
Cantaloupe | CTLP | May 31, 2024 | 7.16 | +0.14 |
Canterbury Park | CPHC | May 31, 2024 | 22.36 | -2.53 |
Capital Bancorp | CBNK | May 31, 2024 | 20.15 | +0.15 |
Capital City Bank Group | CCBG | May 31, 2024 | 27.16 | +0.85 |
Capital One Financial | COF | May 31, 2024 | 137.63 | +1.06 |
Capital One Financial I Pref | COF-I | May 31, 2024 | 19.98 | +3.31 |
Capital One Financial J Pref | COF-J | May 31, 2024 | 18.93 | +3.05 |
Capital One Financial K Pref | COF-K | May 31, 2024 | 18.82 | +4.50 |
Capital One Financial L Pref | COF-L | May 31, 2024 | 17.44 | +3.81 |
Capital One Financial N Pref | COF-N | May 31, 2024 | 17.06 | +4.12 |
Capital Product Partners | CPLP | May 31, 2024 | 17.88 | +0.96 |
Capital Southwest | CSWC | May 31, 2024 | 25.58 | +0.95 |
Capitalworks Emerging Markets Acquisition A | CMCA | May 31, 2024 | 11.04 | +0.29 |
Capitol Federal Financial | CFFN | May 31, 2024 | 5.17 | -0.19 |
Capri Holdings | CPRI | May 31, 2024 | 34.55 | +2.07 |
Capricor Therapeutics | CAPR | May 31, 2024 | 5.68 | +2.34 |
Captivision | CAPT | May 31, 2024 | 4.72 | -3.28 |
Cara Therapeutics | CARA | May 31, 2024 | 0.65 | +8.61 |
Caravelle International Group | CACO | May 31, 2024 | 1.03 | -0.18 |
Carbon Revolution | CREV | May 31, 2024 | 9.00 | -1.96 |
Cardiff Oncology | CRDF | May 31, 2024 | 3.18 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.